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Helminth parasites are known to elicit the immune response towards T helper 2 (Th2)-
type, characterized by Th2 related cytokines, that typically include interleukin-4 (IL-
4), IL-5 and IL-13.  In this review we will describe the mechanisms involved in helminth 
induced Th2 immune response.  Intestinal epithelial cells (IECs) produce thymic stromal 
lymphopoietin (TSLP), which is both necessary and sufficient for the initiation of Th2 
cytokine-driven inflammation.  IL-33 mRNA is expressed early during parasite infection 
and IL-33 binds ST2 receptor, both of which are associated with optimal CD4+ Th2 polar-
ization.  Following innate immune cell recognition, basophils and mast cell can secrete Th2 
type cytokines that are thought to contribute to CD4+ Th2 differentiation.  Additionaly, 
dendritic cell conditioned with some helminth products can promote CD4+ Th2 differen-
tiation.  Alternatively activated macrophages, activated by the Th2 cytokines IL-4 and IL-
13 in parasitic infections, contribute to the host protective response:  control of Th1-type 
inflammation, wound healing and worm expulsion.  Experimentally, helminths have been 
associated with protection against a number of autoimmune disorders, including inflam-
matory bowel diseases and type 1 diabetes.  It may be a novel strategy to ameliorate au-
toimmune inflammation by expanding and activating the Th2 response originated from 
parasites.
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thymic stromal lymphopoietin
Abbreviations:  AAM , alternatively activated macrophage; AMAC, alternative macrophage activation-associated CC 
chemokine; AMCase, acidic mammalian chitinase; CAM , classically activated macrophage; CCR4, CC chemokine recep-
tor 4; DC, dendritic cell; ERK, extracellular signal regulated kinase; ES, excretory/secretory; Fc RI, Fc receptor for IgE; IEC, 
intestinal epithelial cell; IL, interleukin; iNOS, inducible nitric oxide synthase; JNK, c-Jun N-terminal kinase; LPS, lipopoly-
saccharide; MAPK, mitogen-activated protein kinase; NF- B, nuclear factor- B; MDC, macrophage derived chemokine; SEA, 
schistosome egg antigen; SWA, soluble worm antigen; TARC, thymus and activation-regulated chemokine; TIMP, tissue inhib-
itor of metalloproteinase; TGF- , transforming growth factor- ; Th2, T helper 2; TLR, Toll-like receptor; TSLP, thymic stromal 
lymphopoietin
Helminth infections are characterized by a strong 
T helper 2 (Th2)-type response, which includes the 
combined innate and adaptive immune responses 
to clearly distinguish it from the adaptive Th2-
cell response (Anthony et al., 2007).  Th2-type 
responses are typically characterized by increases 
in the levels of Th2-type cytokines such as inter-
leukin-4 (IL-4), IL-5, IL-13 and IL-21.  In this re-
view we will first describe the mechanism of Th2-
cell response evoked by helminth parasite (Fig. 1). 
Second the characterization and the function of 
alternatively activated macrophages (AAM s) acti-
vated by IL-4/IL-13-dependent signal pathway will 
be discussed, and third we will give an overview 
that helminth parasites prevent the autoimmune 
diseases through Th2-type response.
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Th2-type response 
induced by helminth parasites
Innate immune responses:  basophils and 
mast cells
 
Innate immune cells are essential for both the ini-
tiation and effector phases of Th2-type immune 
responses.  Following helminth infection, basophils 
increase in number in the blood and tissues.  In Nip-
postrongylus brasiliensis infection, IL-4-producing 
basophils are readily detected in the lungs, liver and 
spleen (Shinkai et al., 2002; Min et al., 2004).  Ba-
sophils and eosinophils might be a major source of 
IL-4 at early stages of the Th2-cell response, sug-
gesting that they promote the development of Th2 
cells or their recruitment to sites of inflammation.
 Mast cells share many characteristics with 
basophils, including the cell-surface expression of 
the high-affinity Fc receptor for IgE (Fc RI), IL-
18R and the Toll-like receptors (TLRs), and IL-4/
IL-13 secretion (Yoshimoto and Nakanishi, 2006). 
They have also been shown recently to derive from 
a common progenitor (Arinobu et al., 2005).  How-
ever, unlike basophils, which circulate in the blood, 
mast cells reside in peripheral tissues and are thus 
well situated to respond immediately to invasive 
agents.  Increased numbers of mucosal mast cells 
are often observed in affected tissues during hel-
minth infections and this increase is dependent on 
Th2-type cytokines.
 
TSLP
 
Intestinal epithelial cells (IECs) are a critical cell 
population that maintains intestinal immune ho-
meostasis through both barrier function and the 
ability to actively modulate intestinal immune re-
Fig. 1.  The orchestration of CD4+ Th2 cell differentiation following innate cell recognition and response to parasite infec-
tion and the inhibitory mechanism of Th1-dependent autoimmune diseases.  Following innate cell recognition, Th2-type cy-
tokines including IL-4, IL-13 and IL-33, or TLSP are secreted.  These cytokines are thought to contribute to CD4+ Th2 cell 
differentiation.  DC conditioned with helminth products also induces Th2 cell polarizing.  Th2 cytokines and AAM s pre-
vent Th1-dependent autoimmune diseases.  AAM , alternatively activated macrophage; DC, dendritic cell; Eo, eosinophil; 
IEC, intestinal epithelial cell; IL, interleukin; MC, mast cell; Th, T helper; TLR, Toll-like receptor; TSLP, thymic stromal 
lymphopoietin.
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sponses (Zeuthen et al., 2008).  One IEC-derived 
cytokine with immunomodulatory properties is 
thymic stromal lymphopoietin (TSLP).  TSLP is a 
four-helix bundle cytokine that is expressed both in 
humans and mice.  Despite poor sequence homol-
ogy, human and mouse TSLP exhibit similar bio-
logical functions (Liu et al., 2007).  Expression of 
TSLP is regulated by nuclear factor (NF)- B and 
can be induced by exposure to viral, bacterial and 
parasitic pathogens, and inflammatory cytokines 
IL-1  and TNF  (Allakhverdi et al., 2007; Lee et 
al., 2007).  TSLP binds to its high affinity receptor 
(R), a heterodimer composed of a unique TSLPR 
chain and the IL-7R chain, that is expressed on he-
matopoietic cell lineages, including B cells, T cells, 
mast cells and dendritic cells (DCs) (Soumelis et 
al., 2002; Allakhverdi et al., 2007; Chappaz et al., 
2007; Liu et al., 2007).
 TSLP-conditioned human DCs can promote 
Th2 cell responses (Soumelis et al., 2002; Ito et al., 
2005; Rimoldi et al., 2005).  TSLP-treated DCs ex-
hibit reduced production of IL-12/23p40 upon TLR 
ligation, and the ability of DC-derived OX40L to 
drive Th2 cell differentiation is critically dependent 
on the absence of IL-12 (Soumelis et al., 2002; Ito 
et al., 2005; Rimoldi et al., 2005).  TSLP treatment 
of human DCs induces expression of the chemok-
ines CCL17 and CCL22, known ligands for CCR4, 
a chemokine receptor found on effector Th2 cells 
(Soumelis et al., 2002).  More recently, TSLP has 
been reported to act directly on naïve mouse CD4+ 
T cells to promote IL-4 production and to induce 
Th2 cell differentiation in the absence of exogenous 
IL-4 and antigen presenting cells in vitro (Omori 
and Ziegler, 2007).  TSLP is both necessary and 
sufficient for the initiation of Th2 cytokine-driven 
inflammation (Ziegler and Liu, 2006; Liu et al., 
2007).  TSLP–TSLPR interactions are critical for 
immunity to the intestinal pathogen Trichuris. 
Monoclonal antibody-mediated neutralization of 
TSLP or deletion of the TSLPR in normally resis-
tant mice resulted in defective expression of Th2 
cytokines and persistent infection (Taylor et al., 
2009).  However, TSLP-TSLPR interaction has no 
functional impact on the development of protective 
Th2 immune responses after infection with 2 hel-
minth, Heligmosomoides polygyrus and N. brasil-
iensis (Massacand et al., 2009).
 
IL-33
 
IL-33 is produced very early during Trichuris muris 
infection (Humphrey et al., 2008).  IL-33 is struc-
turally closely related to IL-18, requires posttrans-
lational processing, and binds the receptor complex 
consisting of the orphan IL-1R family member ST2 
and the IL-1R accessory protein (Acosta-Rodriguez 
et al., 2007).  ST2 is expressed on mast cells and 
Th2 cells (Nakanishi et al., 2001) and has been 
shown to play an important role in Th2 responses 
(Yoshimoto and Nakanishi, 2006).  IL-33 induces 
IgE-independent production of IL-13 from both 
human and mouse mast cells (Florian et al., 2006) 
and can operate in coordination with the epithelial 
cell-restricted cytokine TSLP on mast cells to max-
imize Th2-associated cytokines and chemokine 
production (Brunner et al., 2004).  Likewise, IL-
33 has been described as a chemoattractant of Th2 
cells (Oshikawa et al., 2001).  The ability of IL-33 
to enhance TSLP-induced responses from mature 
mast cells has recently been demonstrated (Brunner 
et al., 2004).  It is conceivable that IL-33 can act via 
TSLP to promote Th2-driven immunity to T. muris 
infection.
 The IL-17-related cytokine IL-25 (also known 
as IL-17E) is also associated with the Th2-type 
response and can promote Th2-cell differentia-
tion and nematode parasite expulsion (Fallon et al., 
2006; Owyang et al., 2006).
 
The induction of Th2 responses by DCs
 
DCs play a central role in activating CD4+ Th cells. 
The ability of DCs to interpret helminth-inherent 
signals and induce Th2 responses has been illus-
trated by experiments in which mice injected with 
DCs that have been pulsed with extracts of helm-
inths in vitro develop Th2-biased helminth-specific 
responses (MacDonald et al., 2001; Balic et al., 
2004; Leech et al., 2006).  The Th2-polarizing 
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properties of helminths appear to reflect the con-
ditioning of DCs to induce these types of immune 
response, because helminth products can act as 
Th2 adjuvants for unrelated antigens (Holland et 
al., 2000; Okano et al., 2001; Gomez-Garcia et al., 
2006).
 The response of DCs to microbial pathogens 
is mediated in large part via TLRs, with input 
from other pattern recognition receptors such as 
lectins (Medzhitov 2007; van Vliet et al., 2008). 
A striking and significant difference between Th2 
responses and Th1 responses is that the former de-
velop normally in the absence of MyD88 (Helmby 
et al., 2003; Layland et al., 2005).  Analyses of 
signalling events within the NF- B and mitogen-
activated protein kinase (MAPK) pathways have 
revealed significant differences between DCs ex-
posed to helminth products and those stimulated 
with microbial products such as bacterial lipopoly-
saccharide (LPS).  For example, extracellular signal 
regulated kinase (ERK), c-Jun N-terminal kinases 
(JNK) and p38 are heavily phosphorylated after 
exposure of DCs to LPS, but in DCs exposed to 
schistosome egg antigen (SEA), a soluble extract 
of schistosome eggs that is capable of conditioning 
DCs to induce strong Th2 responses, ERK and to 
a lesser extent p38 are phosphorylated, but JNK is 
not (Kane et al., 2004).
 Exposure of DCs to helminth products has 
also been reported to stimulate NF- B activation. 
For example, LNFPIII stimulates rapid, transient 
NF- B nuclear translocation and activation (Thom-
as et al., 2005).  Consistent with these findings, nei-
ther SEA nor LNFPIII-dextran pulsed NF- B1−/− 
DCs are able to induce Th2 responses (Thomas et 
al., 2005; Artis et al., 2005).  LNFPIII and excre-
tory/secretory products (ES)-62, a phosphorylcho-
line-containing protein secreted by the nematode 
Acanthocheilonema viteae, condition DCs to in-
duce Th2 responses through TLR4 (Thomas et al., 
2003; Goodridge et al., 2005).  Lysophosphatidyl-
serine from schistosomes has been reported to trig-
ger DC activation by binding to TLR2 in DCs (van 
der Kleij et al., 2002).
 There has been great interest recently in the 
possibility that C-type lectins represent the major 
class of pattern recognition receptors for helminth 
products.  N-Glycans containing fucose, expressed 
in multiple schistosome life stages, as possessing 
many of the Th2-inducing properties of SEA, as 
described above (Faveeuw et al., 2003; Thomas et 
al., 2003, 2005), and generally indicated a role for 
glycans in the priming of Th2 responses by helm-
inths.
Table 1. Specially upregulated genes in alternatively activated macrophages
 Marker Alternatively activated macrophage Reference
 Pattern recognition receptors Mannose receptor (CD206) Stein et al., 1992
  -glucan receptor Goerdt and Orfanos, 1999
Other receptors IL-4R  Herbert et al., 2004
  Fc RII (CD23) Goerdt and Orfanos, 1999
L-arginine metabolism Arginase-1 Loke et al., 2002
Tissue remodeling factors TGF-  Song et al., 2000
  TIMP1, TIMP2 Sandler et al., 2003
  Fibronectin Gordon, 2003
Chemokines  MDC (CCL22) Bonnecchi et al., 1998
  TARC (CCL17) Imai et al., 1999
  AMAC-1 (CCL18) Goerdt and Orfanos, 1999
Anti-inflammatory effects IL-10 Goerdt and Orfanos, 1999
Th2 type inflammation Ym1, FIZZ1/RELM  Raes et al., 2002
  AMCase Nair et al., 2005
AMAC-1, alternative macrophage activation-associated CC chemokine; AMCase, acidic mammalian chitinase; IL, interleu-
kin; TGF- , transforming growth factor- ; MDC: macrophage derived chemokine; TARC, thymus and activation-regulated 
chemokine; TIMP, tissue inhibitor of metalloproteinase. 
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Alternatively activated macrophages in 
helminth infections
 
Recent studies suggest that macrophages, conven-
tionally associated with IFN -dominant Th1-type 
responses to many bacteria and viruses, also play 
an essential role in the Th2-type inflammatory 
response.  These macrophages are referred to as 
AAM s as they express a characteristic pattern of 
cell surface and secreted molecules distinct from 
that of classically activated macrophages (CAM s) 
associated with microbe infections.
 
Characterization and phenotype
 
The concept of AAM s was first introduced to 
distinguish specifically between the phenotype of 
cells “activated” in the presence of IL-4 and cells 
“deactivated” in the presence of IL-10 (Stein et al., 
1992).  Gordon (2003) later included the effects of 
IL-13 in the definition of alternative activation be-
cause IL-13 shares a common receptor chain with 
IL-4 and exerts similar effects on macrophages. 
Administration of recombinant peroxiredoxisin 
from Fasciola hepatica and Schistosoma mansoni 
to wild type and IL-4–/– and IL-13–/– mice induced 
the production of AAM s independently of IL-4/
IL-13 signaling (Donnelly et al., 2008) (Fig. 1).
 AAM s are observed in a variety of helminth 
infections, including Th2-type immune responses 
to S. mansoni (Herbert et al., 2004), Taenia crassi-
ceps (Rodriguez-Sosa et al., 2002), Trichinella spi-
ralis (Dzik et al., 2004), F. hepatica (Donnelly et 
al., 2005) and filarial parasites (Nair et al., 2003). 
A number of markers are used to identify AAM s 
(Table 1).  Cell surface IL-4R  and the mannose 
receptor (CD206), are readily detected using ei-
ther flow cytometric (Herbert et al., 2004) or im-
munohistologic (Anthony et al., 2006) techniques. 
Arginase-1 is upregulated in AAM s and, due 
to its higher affinity for arginine, competes with 
inducible nitric oxide synthase (iNOS), which me-
tabolizes arginine in CAM s.  Then, AAM  fail 
to generate NO from arginine, and arginase-1 and 
its metabolic products, including urea and proline, 
are also indicative of AAM  differentiation (Loke 
et al., 2002).
 Human AAM s specifically express al-
ternative macrophage activation-associated CC 
chemokine-1 (AMAC-1; CCL18) (Goerdt and Orfa-
nos, 1999), macrophage-derived chemokine (MDC; 
CCL22) (Bonecchi et al., 1998), and thymus and 
activation-regulated chemokine (TARC; CCL17) 
(Imai et al., 1999).  These chemokines preferen-
tially recruit Th2 cells through interaction with the 
CC chemokine receptor 4 (CCR4).
 AAM s express certain chitinase and FIZZ 
(found in inflammatory zone) family member pro-
teins, including: FIZZ1/RELM , Ym1 and acidic 
mammalian chitinase (AMCase) (Nair et al., 2005); 
the Ym1 transcript shows the highest upregulation 
of any gene in AAM s during nematode infection 
(Raes et al., 2002) .
 
Control of inflammation
 
AAM s have multiple roles during helminth in-
fection, one of which is regulation of the immune 
response.  A dominant role for helminth-elicited 
AAM s is suggested to control the underlying 
Th1-type inflammatory responses that may other-
wise contribute to pathogenesis.  Suppressive ef-
fects of AAM s on T cell proliferation can occur 
in murine models of filarial infections.  Brugia ma-
layi L3 injected into the peritoneal cavity can elicit 
AAM s with potent T cell suppressive properties 
(Nair et al., 2005).  Infection with Litomosoides 
sigmodontis also induces AAM s, which can sup-
press in vitro T cell proliferation.  Further in vitro 
studies suggest that the mechanism of T cell sup-
pression is independent of IL-10 and CTLA-4, but 
partially dependent on transforming growth factor 
(TGF)-  (Taylor et al., 2006).  Thus, AAM s ap-
pear to be more important in blocking underlying 
Th1-type responses than promoting Th2-type re-
sponses, including Th2 cells.
 
Wound healing
 
AAM s can contribute to fibrosis and repair at the 
site of injury (Martin and Leibovich, 2005), which 
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may be of considerable importance during helm-
inth infection.  These large metazoan parasites can 
cause extensive damage as they pass through tissue, 
releasing proteolytic enzymes that damage cells 
and tissues.  Genes involved in tissue remodeling, 
including tissue inhibitors of metalloproteinases 
(TIMPs), are upregulated (Sandler et al., 2003). 
FIZZ1/RELMa has recently been implicated in 
wound healing (Liu et al., 2004).
 
Worm expulsion and resistance
 
Elements of the Th2-type response can control 
pathologic Th1-type inflammation and also mar-
shal effective helminth resistance; for example, 
the Th2-type response has a demonstrated role in 
the expulsion of several intestinal nematode para-
sites (Gause et al., 2003; Finkelman et al., 2004). 
Clearly AAM s may contribute to resistance by 
controlling Th1-type immunity and thereby pro-
moting a potent and polarized Th2-type response. 
Recently, it is becoming increasingly apparent that 
AAM s may also promote certain components of 
the Th2-type response important in worm expul-
sion.  For example, AAM s recruit eosinophils 
to the lung and peritoneum during N. brasiliensis 
infection (Voehringer et al., 2007).  Two candidates 
for eosinophil recruitment are leukotriene B4 (Re-
ese et al., 2007) and Ym1, a chitinase-like peptide 
that lacks chitinase activity (Owhashi et al., 2000). 
Related to Ym1, AMCase is a functional chitinase, 
which shows elevated gene expression during H. 
polygyrus or B. malayi infection (Anthony et al., 
2006; Nair et al., 2005).  It is tempting to speculate 
that AMCase may function to damage chitin-con-
taining parasites, including developing microfilaria. 
If so, this would be in addition to its recently de-
scribed function in augmenting Th2-type responses 
by stimulating production of monocyte chemotactic 
protein-1 and eotaxin (Zhu et al., 2004).  The po-
tential multiple roles of Ym1 and AMCase during 
helminth infection make these related molecules 
compelling subjects for future investigations of 
AAM  function.
 These AAM  effector functions can be gen-
erally separated into three categories contributing 
to the host protective response: control of Th1-type 
inflammation, wound healing, and worm expulsion.
 
Table 2.  Helminth infections or products that prevent autoimmune diseases in animal models or humans
 Immunological disease Helminth Agent or product Reference
 (a) Animal models
      Type 1 diabetes Schistosoma mansoni  Infection Cooke et al., 1999
  S. mansoni  SWA, eggs or SEA  Zaccone et al., 2003
  Trichinella spiralis  Infection Saunders et al., 2007
  Dirofilaria immitis Recombinant antigen Imai et al., 2001
      Experimental autoimmune  S. mansoni Infection La Flamme et al., 2003
       encephalitis S. mansoni  Eggs Sewell et al., 2003
      Collagen-induced arthritis Acanthocheilonema viteae ES-62  McInnes et al., 2003
      Experimental colitis S. mansoni  infection Smith et al., 2007
  S. mansoni  Eggs Elliott et al., 2003
  Heligmosomoides polygyrus Infection or  transfer of  Elliott et al., 2004
        MLN from infected mice
  Hymenolepis diminuta Infection Reardon et al., 2001
  T. spiralis Infection Khan et al., 2002
  Trichuris suis  Infection Summers et al., 2003
(b) Human diseases
      IBD:  Crohn’s disease  T. suis Infection Summers et al., 2005a
  Necator americanus Infection Croese et al., 2006
      IBD:  ulcerative colitis  T. suis Infection Summers et al., 2005b
 ES-62, excretory/secretory products of 62 kDa; IBD, inflammatory bowel disease; MLN, mesenteric lymph node; SEA, 
soluble egg antigen; SWA, soluble worm antigen.
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Prevention of
autoimmune diseases by helminth
 
Experimentally, helminths have been associated 
with protection against a number of autoimmune 
disorders, including inflammatory bowel disease 
and diabetes (Table 2a).  The incidence of autoim-
mune type 1 diabetes is on the increase in devel-
oped countries while remaining relatively uncom-
mon in the developing world.  This trend coincides 
with a decrease in helminth infection (Gale, 2002).
 Previous studies have shown that infection 
with S. mansoni, T. spiralis and H. polygyrus can 
significantly inhibit or delay the development of 
diabetes in nonobese diabetic mice (Cooke et al., 
1999).  This appeared to be due to a skewing of the 
diabetes-associated Th1 response towards protec-
tive Th2 responses including IL-4, IL-5, IL-10 and 
IL-13 production (Zaccone et al., 2003).  Admin-
istration of schistosome eggs has been shown to 
reduce the severity of experimental autoimmune 
encephalomyelitis (Sewell et al., 2003) as well as 
preventing the development of both trinitrobenzene 
sulfonic acid-induced colitis (Elliott et al., 2003) 
and diabetes in the nonobese diabetic mouse model 
(Cooke et al., 2004; David et al., 2004).
 Inflammatory bowel disease is the most com-
mon and serious chronic inflammatory condition of 
the gut.  Among the distinct Th cell subsets, a Th1 
type response is associated predominantly with 
Crohn’s disease while helminth infections generate 
a strong Th2 type response.  Inflammatory bowel 
disease is most prevalent in developed countries but 
rare in countries where infections with helminths 
are common.  Both Crohn’s disease and ulcerative 
colitis have a prevalence range of 10 to 200 per 
100,000 individuals per year in North America and 
Europe (Bouma et al., 2003).  Inflammatory bowel 
disease can begin relatively early in life and persist 
for long periods, leading to substantial morbid-
ity and decreased quality of life (Blumberg et al., 
2001).
 Previously it is shown that prior infection 
with the helminth parasite, T. spiralis, ameliorates 
subsequent hapten-induced colitis in mice and this 
was associated with a down-regulation of the Th1 
response (Khan et al., 2002).  This was correlated 
with a down-regulation of myeloperoxidase activ-
ity, IL-1  production and inducible nitric oxide 
synthase (iNOS) and an up-regulation of IL-13 
and TGF-  production in the colon (Motomura et 
al., 2008).  It may be a novel strategy to ameliorate 
colonic inflammation with helminth antigens by 
expanding and activating the Th2 response.
 Recent clinical studies provide evidence that 
Trichuris suis ova therapy is effective in treating 
both Crohn’s disease and ulcerative colitis without 
any adverse effects (Summers et al., 2005a, 2005b) 
(Table 2b).  The outcome of these trials supports 
further the concept that de-worming the population 
has led to the rising prevalence of inflammatory 
bowel disease.
 The ability of TSLP to inhibit IL-12/23p40 
and IFN-  production suggests that TSLP-based 
biologics may also offer a novel therapeutic modal-
ity in the treatment of inflammatory bowel disease 
and other chronic inflammatory disorders.  Con-
sistent with this, TSLP expression was decreased 
in intestinal biopsies from patients with Crohn’s 
disease, suggesting that increased TSLP expression 
may provide therapeutic benefits (Rimoldi et al., 
2005).  Thus, the TSLP–TSLPR pathway may be a 
novel therapeutic target for a variety of inflamma-
tory conditions associated with the overproduction 
of proinflammatory cytokines.
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